SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-16-006937
Filing Date
2016-07-14
Accepted
2016-07-14 16:59:48
Documents
80
Period of Report
2016-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K peregrine_10k-043016.htm 10-K 1062910
2 SUBSIDIARIES peregrine_ex21.htm EX-21 1690
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM peregrine_ex2301.htm EX-23.1 3301
4 CERTIFICATION peregrine_ex3101.htm EX-31.1 7530
5 CERTIFICATION peregrine_ex3102.htm EX-31.2 7513
6 CERTIFICATION peregrine_ex32.htm EX-32 5828
7 GRAPHIC image_001.jpg GRAPHIC 50552
  Complete submission text file 0001019687-16-006937.txt   5389512

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE pphm-20160430.xml EX-101.INS 1100567
9 XBRL SCHEMA FILE pphm-20160430.xsd EX-101.SCH 44187
10 XBRL CALCULATION FILE pphm-20160430_cal.xml EX-101.CAL 69946
11 XBRL DEFINITION FILE pphm-20160430_def.xml EX-101.DEF 214309
12 XBRL LABEL FILE pphm-20160430_lab.xml EX-101.LAB 336658
13 XBRL PRESENTATION FILE pphm-20160430_pre.xml EX-101.PRE 315198
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 161767864
SIC: 2834 Pharmaceutical Preparations